{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T11:46:59Z","timestamp":1768564019844,"version":"3.49.0"},"posted":{"date-parts":[[2023,8,1]]},"group-title":"Oncology","reference-count":16,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  Measurable residual disease (MRD) in adults with acute myeloid leukemia (AML) in complete remission is an important prognostic marker, but detection methodology requires optimization. The persistence of mutated\n                  <jats:italic>NPM1<\/jats:italic>\n                  or\n                  <jats:italic>FLT3<\/jats:italic>\n                  -ITD in the blood of adult patients with AML in first complete remission (CR1) prior to allogeneic hematopoetic cell transplant (alloHCT) has been established as associated with increased relapse and death after transplant. The prognostic implications of persistence of other common AML-associated mutations, such as\n                  <jats:italic>IDH1<\/jats:italic>\n                  , at this treatment landmark however remains incompletely defined. We performed testing for residual\n                  <jats:italic>IDH1<\/jats:italic>\n                  variants (\n                  <jats:italic>IDH1<\/jats:italic>\n                  m) in pre-transplant CR1 blood of 148 adult patients undergoing alloHCT for\n                  <jats:italic>IDH1<\/jats:italic>\n                  -mutated AML at a CIBMTR site between 2013-2019. No post-transplant differences were observed between those testing\n                  <jats:italic>IDH1<\/jats:italic>\n                  m positive (n=53, 36%) and negative pre-transplant (overall survival: p = 0.4; relapse: p = 0.5). For patients with\n                  <jats:italic>IDH1<\/jats:italic>\n                  mutated AML co-mutated with\n                  <jats:italic>NPM1<\/jats:italic>\n                  and\/or\n                  <jats:italic>FLT3<\/jats:italic>\n                  -ITD, only detection of persistent mutated\n                  <jats:italic>NPM1<\/jats:italic>\n                  and\/or\n                  <jats:italic>FLT3<\/jats:italic>\n                  -ITD was associated with significantly higher rates of relapse (p = 0.01). These data, from the largest study to date, do not support the detection of\n                  <jats:italic>IDH1<\/jats:italic>\n                  mutation in CR1 blood prior to alloHCT as evidence of AML MRD or increased post-transplant relapse risk.\n                <\/jats:p>","DOI":"10.1101\/2023.07.28.23293166","type":"posted-content","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T10:00:11Z","timestamp":1690884011000},"source":"Crossref","is-referenced-by-count":2,"title":["Measurable Residual\n                  <i>IDH1<\/i>\n                  before Allogeneic Transplant for Acute Myeloid Leukemia"],"prefix":"10.64898","author":[{"given":"Gege","family":"Gui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4877-9354","authenticated-orcid":false,"given":"Laura W.","family":"Dillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niveditha","family":"Ravindra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pranay S.","family":"Hegde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgia","family":"Andrew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devdeep","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zo\u00eb","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffery","family":"Auletta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Firas El","family":"Chaer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Bin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Corner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M.","family":"Devine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio Martin","family":"Jimenez Jimenez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos J.G.","family":"De Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark R.","family":"Litzow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Partow","family":"Kebriaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen R","family":"Spellman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott L.","family":"Zeger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin M.","family":"Page","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6189-8067","authenticated-orcid":false,"given":"Christopher S.","family":"Hourigan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2023080303250522000_2023.07.28.23293166v1.1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021013626"},{"issue":"12","key":"2023080303250522000_2023.07.28.23293166v1.2","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1001\/jamaoncol.2020.4600","article-title":"Association of Measurable Residual Disease With Survival Outcomes in Patients With Acute Myeloid Leukemia: A Systematic Review and Meta-analysis","volume":"6","year":"2020","journal-title":"JAMA Oncol"},{"issue":"1","key":"2023080303250522000_2023.07.28.23293166v1.3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/hematology.2022000323","article-title":"Achieving MRD negativity in AML: how important is this and how do we get there?","volume":"2022","year":"2022","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"9","key":"2023080303250522000_2023.07.28.23293166v1.4","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1001\/jama.2023.1363","article-title":"DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant","volume":"329","year":"2023","journal-title":"JAMA"},{"key":"2023080303250522000_2023.07.28.23293166v1.5","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0623-z"},{"issue":"20","key":"2023080303250522000_2023.07.28.23293166v1.6","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1182\/blood.2020010165","article-title":"Prognostic significance of concurrent gene mutations in intensively treated patients with IDH-mutated AML: an ALFA study","volume":"137","year":"2021","journal-title":"Blood"},{"issue":"5","key":"2023080303250522000_2023.07.28.23293166v1.7","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1182\/bloodadvances.2021004934","article-title":"Differential impact of IDH1\/2 mutational subclasses on outcome in adult AML: results from a large multicenter study","volume":"6","year":"2022","journal-title":"Blood Adv"},{"key":"2023080303250522000_2023.07.28.23293166v1.8","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0026-z"},{"key":"2023080303250522000_2023.07.28.23293166v1.9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-693879"},{"issue":"1","key":"2023080303250522000_2023.07.28.23293166v1.10","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13045-022-01339-8","article-title":"Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation","volume":"15","year":"2022","journal-title":"J Hematol Oncol"},{"key":"2023080303250522000_2023.07.28.23293166v1.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2117344"},{"key":"2023080303250522000_2023.07.28.23293166v1.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716984"},{"key":"2023080303250522000_2023.07.28.23293166v1.13","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001503"},{"issue":"11","key":"2023080303250522000_2023.07.28.23293166v1.14","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1158\/1078-0432.CCR-23-0182","article-title":"Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for IDH1-Mutated Acute Myeloid Leukemia","volume":"29","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"3","key":"2023080303250522000_2023.07.28.23293166v1.15","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1182\/bloodadvances.2021005789","article-title":"Impact of IDH1 and IDH2 mutation detection at diagnosis and in remission in patients with AML receiving allogeneic transplantation","volume":"7","year":"2023","journal-title":"Blood Adv"},{"key":"2023080303250522000_2023.07.28.23293166v1.16","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.191148"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2023.07.28.23293166","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T19:38:03Z","timestamp":1768505883000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2023.07.28.23293166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":16,"URL":"https:\/\/doi.org\/10.1101\/2023.07.28.23293166","relation":{},"subject":[],"published":{"date-parts":[[2023,8,1]]},"subtype":"preprint"}}